The deadly implications of counterfeit drugs are well understood to be a central challenge to the integrity of public health systems around the globe, as well as a direct threat to our individual health and welfare. What is less understood is that the profits from this sinister crime are increasingly being co-opted by an array of organized criminal groups and terrorist entities as a means by which to fund their nefarious operations around the world.
Recent trends suggest a massive increase in counterfeit drug sales to over $70 billion globally in 2010. This is an increase of more than 90 percent from 2005. Although the counterfieting of, and trafficking in, all manner of products is on the rise globally (including currency, documents, software, and electronics) no other bogus product has the capacity to harm or even kill its consumer as do illicit pharamceuticals.